Shannon M. Winters

Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study

Gary E. Raskob, Walter Ageno, Alexander T. Cohen et al. · The Lancet Haematology · 2016 · 67 citations

Medicine, Hematology, Pharmacotherapy +16

Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists

Gary E. Raskob, Harry R. Büller, Michael Grosso et al. · Thrombosis and Haemostasis · 2017 · 50 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial

Thomas Vanassche, Peter Verhamme, Philip S. Wells et al. · Thrombosis Research · 2017 · 31 citations

Medicine, Pharmacology, Pharmacotherapy +14

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis

José Luís Merino, Gregory Y.H. Lip, Hein Heidbüchel et al. · EP Europace · 2019 · 28 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF)

Gregory Y.H. Lip, José Luís Merino, Maciej Banach et al. · The American Journal of Cardiology · 2018 · 17 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15